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Abstract Wig-1 is a p53-induced zinc ﬁnger protein. Here we
show that human Wig-1 binds long (P23 bp) dsRNAs with 5 0-
overhangs. The ﬁrst zinc ﬁnger domain is necessary but not suf-
ﬁcient for this dsRNA-binding in vitro. Wig-1 also binds dsRNA
in living cells via zinc ﬁngers 1 and 2. Both zinc ﬁngers 1 and 2
are important for Wig-1-mediated growth suppression. More-
over, Wig-1 binds 21 bp dsRNAs with 3 0-protruding ends. These
ﬁndings demonstrate that human Wig-1 can bind diﬀerent types
of dsRNAs, including dsRNAs resembling small interfering
RNAs (siRNAs) and microRNAs (miRNAs), and indicate that
dsRNA binding has a role in Wig-1-mediated regulation of cell
growth.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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1. Introduction
The p53 tumor suppressor protein is a transcription factor
with sequence-speciﬁc DNA binding activity. p53 accumulates
in response to cellular stress and modulates transcription of
downstream target genes, resulting in cell cycle arrest, apopto-
sis and/or senescence (for a review see [1]). Induction of genes
such as p21 and GADD45 triggers cell cycle arrest whereas
upregulation of Bax, CD95/Fas, and PUMA leads to cell death
by apoptosis. We have previously identiﬁed a novel p53-regu-
lated mouse gene designated wig-1 [2]. Wig-1 encodes a protein
containing three Cys2His2-type zinc ﬁngers that are almost per-
fectly conserved between ﬁsh, and man [3]. Wig-1 mRNA is
constitutively expressed in brain and testis and further in-
creased in lung, kidney and spleen after whole body gamma-
irradiation that activates p53. The wig-1 promoter has two
functional p53-binding sites and confers p53-dependent tran-
scriptional regulation in reporter assays, demonstrating that
wig-1 is a bona ﬁde p53-target gene [4]. Ectopically expressed
human Wig-1 can suppress cell growth by 25–30% in a colony
formation assay but does not induce signiﬁcant cell cycle arrest
or apoptosis [5].
Wig-1 shares structural similarities with two other zinc ﬁnger
proteins, JAZ and dsRBP-ZFa, that bind dsRNA [6,7]. All
three proteins contain long linkers separating adjacent zinc
ﬁngers and a characteristic inter-histidine space of ﬁve amino
acid residues. We have shown that mouse Wig-1 binds dou-
ble-stranded RNA via the ﬁrst zinc ﬁnger domain [8]. This
indicated that Wig-1 is a member of the same group of
dsRNA-binding proteins as JAZ and dsRBP-ZFa, and raised
the possibility that dsRNA-binding plays a role in the p53-
dependent biological response.
Here we have investigated the binding of human Wig-1 to
dsRNA and other nucleic acids. We found that human Wig-
1 binds 50–100 bp long dsRNA via the most N-terminal zinc
ﬁnger domain, and that Wig-1 can bind endogenous dsRNAs
in living cells. We also found that human Wig-1 binds to 21 bp
dsRNA with structural characteristics of siRNAs and mi-
RNAs. This raises the possibility that Wig-1 plays a role in
gene regulation mediated by siRNAs and/or miRNAs.
2. Materials and methods
2.1. Cell culture
Saos-2 cells were grown in Dulbecco’s modiﬁed Eagle Medium
(Sigma-Aldrich, Germany) supplemented with 10% fetal bovine serum
(Sigma-Aldrich), 4 mM L-glutamine and 40 lg/ml gentamicin (Invitro-
gen BV, NL).
2.2. Generation of cells expressing Tet-regulated human wig-1
Saos-2 osteosarcoma cells expressing tetracycline-regulated Flag-
tagged Wig-1 were obtained by transfecting the pUHD172-1neo plas-
mid (Clontech, USA) expressing the tetracycline (Tet)-On regulator
followed by the pTRE2pur-Flag-Wig-1 plasmid using calcium phos-
phate. Positive clones were identiﬁed by Western blotting using anti-
FLAG monoclonal antibody. Cells were grown as above except that
the medium was supplemented with 10% reduced tetracycline fetal
bovine serum (Clontech), 200 lg/ml G418 and 0.5 lg/ml puromycin
(Sigma-Aldrich).
2.3. Human Wig-1 mutants
Mutant constructs were generated using the Site-directed Mutagen-
esis kit (Clontech) following the manufacturer’s instructions. The ZF1
only mutant corresponding to amino acid residues 72–94 was gener-
ated by ampliﬁcation of this region by PCR using pGEM-T-Easy-
human Wig-1 as the template and the primers shown in Table S1.
All mutants were subcloned into the pCMVTag2B vector (Stratagene,
USA) or the pGEX-2 T plasmid for the generation of fusion proteins.
2.4. Expression and puriﬁcation of recombinant proteins
Fusion proteins were expressed in E. coli BL21 codon plus (Strata-
gene) and puriﬁed as described [9].
Abbreviations: ds, double-stranded; dsRBP, double-stranded RNA
binding protein; FL, full-length; GST, glutathione S-transferase;
miRNA, micro RNA; NLS, nuclear localization signal; siRNA, small
interfering RNA; ss, single-stranded; Tet, tetracycline
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2.5. EMSA
The 172 bp dsDNA and the 160 bp ssRNA probes were generated
as described [6,8]. The 100 bp dsRNA probe was prepared as de-
scribed for the 130 bp dsRNA probe in [8]. The 50 bp dsRNA probe
was made by adding a T7 promoter by PCR to a 50 bp sequence
corresponding to pBluescript II KS (+) and SK (+) multiple cloning
site, followed by annealing of complementary strands as described
for the 100 bp dsRNA probe. The 160 bp DNA–RNA hybrid was
synthesized as described [6,8]. The 21 bp dsRNA probes (siRNA/
miRNA-like dsRNAs) were prepared using the Silencer siRNA con-
struction kit (Ambion, TX) following the manufacturer’s instruc-
tions. The probes were constructed using two oligos corresponding
to the pBluescript II KS (+) cloning cassette sequence or to an unre-
lated sequence (Table S1) annealed to the T7 promoter oligo
(provided in the kit) and in vitro transcribed in the presence of
a-32P-CTP (Amersham Pharmacia Biotech, Uppsala, Sweden). The
22 bp dsRNA probes were prepared as described for the siRNA/
miRNA probe using oligos annealed to the T7 promoter (Table
S1) except that these probes were not treated with RNAse. Labeled
probes were gel-puriﬁed and eluted in nuclease-free water. For gel
shift assays, increasing amounts of protein (0.1–100 ng) were incu-
bated with approximately 0.5 ng nucleic acid probes and processed
as described [8].
2.6. Antibodies, immunoprecipitation and immunoblotting
Puriﬁed GST-Wig-1 was used to immunize rabbits (Cambridge Re-
search Biochemicals, UK). Aﬃnity puriﬁed antibodies were prepared
on a Sepharose 4B column with coupled recombinant human Wig-1
(Amersham Pharmacia Biotech, Uppsala, Sweden). The speciﬁcity of
the antibodies was tested by Western blotting using recombinant
human Wig-1 and total cell extracts. Saos-2 Tet-On Wig-1, Saos-2
Tet-On ZF1pm and Saos-2 Tet-On ZF2pm cells were treated with
2 lg/ml doxycycline for induction of Wig-1 expression. Immunopre-
cipitations were performed by adding 1 lg of anti-dsRNA J2 antibod-
ies (Biocenter Ltd., Hungary). Eluted samples and 2.5% of the inputs
were resolved by SDS–PAGE followed by immunoblotting using
anti-Wig-1 rabbit antiserum diluted 1:1000 or a monoclonal anti-b-ac-
tin antibody (Sigma-Aldrich).
2.7. Colony formation assays
Saos-2 cells (75000 cells) were transfected in 6-well plates using cal-
cium phosphate with empty vector (pCMVTag2B), wild type Wig-1,
ZF1pm or ZF2pm in triplicates, transferred to 10 cm plates and al-
lowed to attach for 24 h prior to selection with G418 (1.5 mg/ml). Cells
were grown under selection for around two weeks and colonies stained
with Giemsa. Plates were counted as an average of triplicates in three
separate experiments.
3. Results
3.1. Human Wig-1 binds dsRNA with high aﬃnity
We examined Wig-1 dsRNA binding in EMSA using recom-
binant GST-full-length human Wig-1 protein. Human Wig-1
protein binds preferentially to dsRNA compared to ssRNA
(Fig. 1A). The complex between Wig-1 and the 100 bp dsRNA
probe (Fig. 1A, lane 2) was competed out with increasing con-
centrations of unlabeled dsRNA probe (Fig. 1A, lanes 3–8).
An unlabeled 160 bp ssRNA probe was much less eﬃcient in
blocking Wig-1-dsRNA binding (Fig. 1A, lanes 9–14). This
was conﬁrmed in gel shift experiments using a labeled ssRNA
probe and unlabeled ssRNA or dsRNA as competitors
(Fig. 1B). Wig-1 could bind ssRNA of similar size and se-
quence of the dsRNA probe used in Fig. 1A (Fig. 1B, lane
2). However, both ssRNA (Fig. 1B, lanes 3–8) and dsRNA
(Fig. 1B, lanes 9–14) could compete out the Wig-1/ssRNA
complex. No binding of Wig-1 to dsDNA was observed (data
not shown). Addition of Wig-1 antibody caused a further
retardation of the Wig-1/dsRNA (Fig. 1A, lane 15) and
Wig-1/ssRNA (Fig. 1B, lane 15) complexes, demonstrating
the presence of human Wig-1 protein. Wig-1 also binds
DNA–RNA hybrids although with a lower aﬃnity compared
to a dsRNA of similar size and sequence (Figs. 1C and D).
The complexes between Wig-1 and the DNA–RNA hybrid
(Fig. 1C, lane 1) could be competed out by the addition of
unlabeled DNA–RNA hybrid (Fig. 1C, lanes 2–7) and also
by the unlabeled 100 bp dsRNA probe (Fig. 1C, lanes 8–13).
In contrast, the Wig-1/dsRNA complexes were eﬃciently com-
peted out only by unlabeled dsRNA probe (Fig. 1D, lanes 2–
7) and not with unlabeled DNA–RNA hybrid (Fig. 1D, lanes
8–13), indicating a higher aﬃnity of Wig-1 for the 100 bp
dsRNA.
3.2. Mapping of the dsRNA binding activity
To determine the regions(s) in human Wig-1 that are in-
volved in dsRNA binding, we analyzed a set of deletion
and point mutant GST-Wig-1 fusion proteins (Fig. S1).
Increasing amounts of GST-Wig-1 proteins were incubated
with the labeled dsRNA probe and analyzed in EMSA. Mu-
tants with deleted or point mutant N-terminal zinc ﬁnger do-
main (DZF1, ZF1pm, ZF1 + 2pm) failed to bind dsRNA
whereas all other mutants retained dsRNA binding with sim-
ilar aﬃnity as full-length (FL) Wig-1 (Fig. 2). The N-terminal
zinc ﬁnger domain could not confer dsRNA-binding to the
glutathione S-transferase (GST) protein (Fig. 2, ZF1 only),
indicating that zinc ﬁnger 1 is necessary but no suﬃcient for
dsRNA binding.
3.3. Human Wig-1 interacts with endogenous dsRNA
To determine if Wig-1 can bind cellular dsRNA, we immu-
noprecipitated dsRNA from Saos-2 cells expressing Tet-regu-
lated human Wig-1 using dsRNA-speciﬁc J2 antibodies
[10,11]. Bound human Wig-1 was detected by Western blotting
using anti-human Wig-1 antibodies. Human Wig-1 was specif-
ically co-immunoprecipitated from the Wig-1-expressing cells
with the J2 antibodies but not with an unrelated control anti-
body (b-actin) (Fig. 3; data not shown), indicating that Wig-1
is able to bind endogenous dsRNA in living cells. We per-
formed similar experiments using Saos-2 Tet-On cell lines
expressing ZF1 or ZF2 point mutant Wig-1. The ZF1 point
mutant (ZF1pm) has a His to Ala substitution at residue 88
in the ﬁrst zinc ﬁnger domain and does not bind dsRNA
in vitro. The ZF2 point mutant (ZF2pm) has a His to Ala sub-
stitution at residue 165 in the second zinc ﬁnger and retains
dsRNA-binding activity in vitro. Neither the ZF1 mutant
nor the ZF2 mutant could be immunoprecipitated with the
J2 antibody (Fig. 3). Thus, both mutants show impaired bind-
ing to endogenous dsRNA in living cells.
3.4. Zinc ﬁnger domains 1 and 2 are important for
Wig-1-mediated growth suppression
We tested the requirement of intact zinc ﬁngers 1 and 2 for
Wig-1-mediated growth inhibition in a colony formation
assay in Saos-2 cells. Wild type Wig-1 inhibited growth by
approximately 50% as compared to empty vector. The zinc
ﬁngers 1 and 2 mutants inhibited colony formation by 9%
(ZF1pm) and 24% (ZF2pm), respectively (Fig. 4). Thus, the
ZF1 point mutant had only a minor growth inhibitory eﬀect.
The ZF2 point mutant was slightly more eﬃcient than the
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ZF1 mutant but substantially less eﬃcient than wild type
Wig-1. We conclude that both zinc ﬁngers are important for
Wig-1-mediated growth inhibition.
3.5. dsRNA length requirement
To determine the length requirement for Wig-1 dsRNA
binding, we compared binding to dsRNAs of 100, 50 and
22 bp in EMSA. Human Wig-1 bound the 50 bp dsRNA probe
with roughly the same aﬃnity as the 100 bp dsRNA (Fig. 5A).
The Wig-1/100 bp dsRNA complex could be competed out by
increasing amounts of both, unlabeled 100 bp or 50 bp, ds-
RNAs (Fig. 5B, lanes 2–4 and 5–7, respectively). Identical
results were obtained when 50 bp dsRNA was used as labeled
probe (Fig. 5B, lanes 8–14). In contrast, Wig-1 was unable to
bind a 22 bp dsRNA probe (22 bp dsRNA 1), indicating that
the lower length limit for Wig-1 dsRNA binding is between
22 and 50 bp (Fig. 5C).
3.6. Binding of Wig-1 to siRNA/miRNA-like RNAs in vitro
We also asked if Wig-1 could bind a short siRNA/miRNA-
like dsRNA probe with the same sequence as the 22 bp dsRNA
probe 1 used in the previous experiments but carrying 2 nt 3 0-
protruding ends with 5 0-phosphate and free 3 0-hydroxyl termini
[12,13] instead of 3 nt 5 0-overhangs. Wig-1 bound the 21 bp
siRNA/miRNA -like dsRNA probe 1 (Fig. 5D) but failed to
bind the 22 bp dsRNA probe 1 containing 5 0-overhangs, as pre-
viously observed (Fig. 5C). This shows that Wig-1 can bind
small dsRNAs that carry structural features of siRNAs and
miRNAs. Another 22 bp siRNA/miRNA-like dsRNA pair
was constructed using a sequence unrelated to the pBluescript
plasmid (siRNA/miRNA-like dsRNA probe 2 and 22 bp
dsRNA probe 2). Again, Wig-1 could bind the siRNA/
miRNA-like dsRNA but not the 22 bp dsRNA with 5 0-over-
hangs, indicating that the binding is sequence-independent
(Fig. 5E).
Fig. 1. Electromobility shift assay (EMSA) of human Wig-1 binding to dsRNA. (A) A radiolabeled 100 bp dsRNA probe was incubated with 20 ng
of bacterially produced GST-Wig-1 protein. Increasing amounts of unlabeled dsRNA or ssRNA probes were used as competitors (up to 200-fold
excess over labeled probe). (B) Same as in (A) except that the labeled probe used was a 160 bp ssRNA. (C) GST-human Wig-1 protein was incubated
with the 32P-labeled 160 bp DNA–RNA hybrid probe and analyzed by PAGE. In the competition experiments, the indicated amounts of the
unlabeled 160 bp DNA–RNA hybrid probe or the unlabeled 100 bp dsRNA probe were added. (D) Same as (C) except that the labeled probed used
was the 100 bp dsRNA probe.
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Fig. 2. The ﬁrst zinc ﬁnger in human Wig-1 is necessary but not suﬃcient for binding to dsRNA. Increasing amounts of full-length GST-Wig-1 and
mutants (0.5–100 ng) were tested in EMSA for their ability to bind a labeled 100 bp dsRNA probe.
Fig. 3. Human Wig-1 binds endogenous cellular dsRNA. Immuno-
precipitation experiments were carried out in Saos-2 Tet-On cells
expressing human wild type Wig-1 or ZF1 or ZF2 point mutant Wig-1
in the absence or presence of doxycycline. After 48 h of treatment,
total protein cell lysates were prepared and incubated with J2
antibodies or b-actin antibodies as a control. The bound human
Wig-1 protein was analyzed by immunoblotting using anti-human
Wig-1 antibodies.
Fig. 4. Colony formation assay of Wig-1 zinc ﬁnger mutants. Saos-2
cells were transfected with empty vector, Wig-1 ZF1 mutant or Wig-1
ZF2 point mutant, allowed to form colonies, and stained with Giemsa.
The plates were counted as an average of triplicates in three separate
experiments.
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Incubation of Wig-1 with the 100 bp dsRNA and anti-Wig-1
antibodies gave rise to a supershifted band (Fig. 1A, lane 15).
Intriguingly, anti-Wig-1 antibodies completely blocked Wig-1
binding to the siRNA/miRNA-like probe (Figs. 5D and E,
lanes marked with a black triangle). This suggests that Wig-1
binds short and long dsRNAs through diﬀerent regions. To test
this, we examined if the ﬁrst zinc ﬁnger domain is also involved
in the binding of Wig-1 to small dsRNAs. GST-Wig-1 mutant
(ZF1pm, ZF2pm, ZF3pm, ZF1+ZF2pm, DN and DNLS) fu-
sion proteins were incubated with a labeled siRNA/miRNA
probe and analyzed by EMSA. Most Wig-1 mutants tested,
particularly the ZF1, ZF2, and ZF3 point mutants and the
DNLS mutant, bound the siRNA/miRNA-like probe 2 with
lower aﬃnity compared to the wild type protein (Fig. 6). This
result indicates that all three zinc ﬁnger domains are involved
in binding to short siRNA/miRNA-like dsRNAs in vitro. Thus,
the structural requirements for in vitro binding to long dsRNA
and short siRNA/miRNA-like dsRNA appear diﬀerent.
Fig. 5. dsRNA length requirement for Wig-1 binding. (A) Wig-1 binds a 50 bp dsRNA probe. Increasing amounts of GST-Wig-1 protein were
incubated with a radiolabeled 50 bp dsRNA probe and analyzed by PAGE. (B) Wig-1 binds 50 bp and 100 bp dsRNA with the same aﬃnity. The
indicated radiolabeled probes (marked with an asterisk) were incubated with 20 ng of GST-Wig-1 protein and analyzed by PAGE. In the competition
experiments, the indicated amounts of the unlabeled 50 bp dsRNA or an unlabeled 100 bp dsRNA probe were added. (C) Wig-1 does not bind a
22 bp dsRNA in vitro. Increasing amounts of GST-Wig-1 were incubated with a 22 bp dsRNA probe (22 bp dsRNA probe 1) containing 5 0-
overhangs and resolved by PAGE. (D) Wig-1 binds siRNA/miRNA-like dsRNA. Increasing amounts of GST-Wig-1 protein were incubated with a
radiolabeled siRNA/miRNA-like probe (siRNA/miRNA-like dsRNA probe 1) and resolved by PAGE. (E) Same as in (D) but using siRNA/miRNA-
like and 22 bp dsRNA probes with unrelated sequence (siRNA/miRNA-like dsRNA probe 2 and 22 bp dsRNA probe 2).
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4. Discussion
Wig-1 belongs to a newly described family of dsRNA-bind-
ing proteins that also includes JAZ and dsRBP-ZFa. The
structural similarities between these proteins, including their
unusual distribution of zinc ﬁngers, suggest that they are func-
tionally related. Our ﬁnding that human Wig-1 also binds
dsRNA supports this notion. Like JAZ and dsRBP-ZFa,
human Wig-1 preferentially binds to dsRNA as compared to
ssRNA or dsDNA of corresponding size. In addition, Wig-1
binds DNA–RNA hybrids, although with a lower aﬃnity com-
pared to dsRNA. Importantly, we were able to co-immunopre-
cipitate human Wig-1-dsRNA complexes using antibodies that
speciﬁcally recognize dsRNA molecules longer than 40 bp
Fig. 6. Binding of Wig-1 mutants to siRNA/miRNA-like dsRNA. Increasing amounts of GST-Wig-1 wild type and mutant proteins were incubated
with radiolabeled siRNA/miRNA-like dsRNA probe 2 and analyzed by PAGE.
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[10,11]. Thus, human Wig-1 interacts with endogenous dsRNA
in living cells, indicating that the interaction is physiologically
relevant. Its exact biological role remains unclear, however (see
also below).
Given that FL Wig-1 can bind dsRNA both in vitro and in
living cells, we also examined the ability of two Wig-1 mutants
with diﬀerent dsRNA binding properties in vitro to bind
endogenous cellular dsRNA. We conﬁrmed that the ﬁrst zinc
ﬁnger of Wig-1 is essential for the binding to dsRNA
in vitro as well as in living cells. The ZF2 point mutant was
also deﬁcient in binding to endogenous dsRNA, although it
did bind dsRNA in vitro. One possible reason for this discrep-
ancy is that the ZF2 point mutant can bind dsRNA only
in vitro when present at high concentrations, but not under
more physiological conditions.
So far, two activities have been ascribed to Wig-1, dsRNA
binding and growth suppression [8,14]. This raises the ques-
tion whether these activities are related to each other. We
therefore assessed the ability of wild type Wig-1 and the
ZF1 and ZF2 point mutants to suppress colony formation.
The two ZF mutants were signiﬁcantly and reproducively less
eﬃcient than wild type Wig-1 in this regard. This indicates
that the ZF1 and ZF2 domains are both important for
Wig-1-mediated growth suppression, and suggests that
dsRNA binding through these domains plays a role in this
activity.
What is the physiological dsRNA target of Wig-1? Double-
stranded RNAs originate in cells for example during the nor-
mal course of gene expression or after viral replication. In
addition, intramolecular dsRNA local hairpin structures are
created through long-distance base-pairing such as those seen
in ribosomal RNA [15]. The binding of Wig-1 to endogenous
dsRNAs and its nuclear/nucleolar subcellular localization sup-
ports a model already suggested by us and others [6,8] in which
Wig-1 binding to ribosomal RNA could interfere with ribo-
some biogenesis leading to inhibition of protein synthesis,
growth suppression, and ultimately cell death.
We found that Wig-1 binds long dsRNA (50–100 bp) but
not a 22 bp dsRNA in vitro, indicating a minimal length of
23–50 bp for binding. Interestingly, however, Wig-1 bound
to a 21 bp dsRNA structurally resembling siRNAs and the re-
lated miRNAs. This binding seems to diﬀer from the binding
to longer dsRNAs in several ways. First, our in vitro binding
assays indicated that binding to 100 bp dsRNA to a large ex-
tent is dependent on an intact ZF1 domain whereas binding to
21 bp siRNA/miRNA-like dsRNA seems to involve all three
zinc ﬁnger domains. Second, Wig-1 antibodies supershifted
the Wig-1/100 bp dRNA complexes but completely blocked
complex formation between Wig-1 and the siRNA/miRNA-
like probe. Third, complex formation between Wig-1 and
the siRNA/miRNA-like probe requires twenty times more
protein than binding to the 100 bp dsRNA probe, indicating
a higher aﬃnity of Wig-1 for long dsRNAs as compared to
short siRNA/miRNA-like dsRNAs. We have not been able
to assess binding of Wig-1 to short dsRNAs in living cells,
since the antibodies used only recognize dsRNAs longer than
40 bp.
miRNAs are abundant and ubiquitous in all organisms and
probably play many important roles in cells. The bantam gene
encodes a miRNA that controls cell proliferation and apopto-
sis during Drosophila development by regulating the pro-apop-
totic gene hid [16]. A growing list of miRNAs, the so-called
oncomirs, appear to function as negative or positive growth
regulators in mammalian cells and play a role in cancer [17].
Our observation that Wig-1 binds siRNAs/miRNAs in vitro
raises the possibility that Wig-1 is involved in miRNA-medi-
ated regulation of cell growth and survival, acting to promote
p53-induced cell growth arrest and/or apoptosis. It is conceiv-
able that Wig-1 binding to speciﬁc miRNAs could increase the
stability of the imperfect small duplex regions formed by the
miRNA and its mRNA targets. This could aﬀect mRNA sta-
bility, transport, and/or translation. Further functional studies
of Wig-1 mutants lacking dsRNA binding activity should ulti-
mately clarify the role of Wig-1 dsRNA binding in the p53
tumor suppressor pathway.
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